Home  
  Our Team  
  Patient Info  
  Services  
   
  Pay My Bill  
  Contact Us  

News for Healthier Living

KIMS Expands Plasmonic Liquid Biopsy Platform to Early-Stage Colorectal Cancer!

CHANGWON, South Korea -- Korea Institute of Materials Science (KIMS), led by President Chul-jin Choi, announced that a research team led by Minyoung Lee and Sunggyu Park of the Bio & Health Materials Research Division has developed a plasmonic-based liquid biopsy platform capable of ultrasensitive detection of KRAS mutations in the blood and urine of patients with early-stage colorectal cancer. By analyzing matched tumor tissue, plasma, and urine samples from patients with Stage 0 and Stage I colorectal cancer, the researchers demonstrated over 90% concordance in KRAS mutation status across the three specimen types, supporting the platform's potential as a non-invasive precision cancer diagnostic technology.

July 8, 2026


July 10 2026

July 9 2026

July 8 2026

July 7 2026

July 6 2026

July 3 2026

July 2 2026

July 1 2026

June 30 2026

June 29 2026